Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

16 Aug 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Parkinson's Disease Mechanisms and Treatments
Share to Plant Gene Expression Analysis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19684592
DOI: 10.1038/nn.2372

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron lossPMID 19684592Read ↗

Unraveling the AKT/ERK cascade and its role in Parkinson diseaseSemantic proximity Read ↗

Recent developments in the treatment of Parkinson's DiseaseSemantic proximity Read ↗

Shedding new light on neurodegenerative diseases through the mammalian target of rapamycinSemantic proximity Read ↗

Protein Kinases and Parkinson’s DiseaseSemantic proximity Read ↗

Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson DiseaseSemantic proximity Read ↗

LRRK2 inhibitor progresses for Parkinson disease.Semantic proximity Read ↗

The mTOR signalling cascade: paving new roads to cure neurological diseaseSemantic proximity Read ↗

Anti-Parkinsonian effects of Bacopa monnieri: Insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s diseaseSemantic proximity Read ↗

Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybridsSemantic proximity Read ↗

Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signalingSemantic proximity Read ↗

Upcoming treatments in Parkinson's disease, including gene therapySemantic proximity Read ↗

Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal deathSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.